Esteller M - Search Results

1

BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer.

Stefansson OA, Villanueva A, Vidal A, Martí L, Esteller M. Stefansson OA, et al. Among authors: esteller m. Epigenetics. 2012 Nov;7(11):1225-9. doi: 10.4161/epi.22561. Epub 2012 Oct 15. Epigenetics. 2012. PMID: 23069641 Free PMC article.

2

A systematic profile of DNA methylation in human cancer cell lines.

Paz MF, Fraga MF, Avila S, Guo M, Pollan M, Herman JG, Esteller M. Paz MF, et al. Among authors: esteller m. Cancer Res. 2003 Mar 1;63(5):1114-21. Cancer Res. 2003. PMID: 12615730

3

Relevance of DNA methylation in the management of cancer.

Esteller M. Esteller M. Lancet Oncol. 2003 Jun;4(6):351-8. doi: 10.1016/s1470-2045(03)01115-x. Lancet Oncol. 2003. PMID: 12788407 Review.

4

Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.

Ballestar E, Paz MF, Valle L, Wei S, Fraga MF, Espada J, Cigudosa JC, Huang TH, Esteller M. Ballestar E, et al. Among authors: esteller m. EMBO J. 2003 Dec 1;22(23):6335-45. doi: 10.1093/emboj/cdg604. EMBO J. 2003. PMID: 14633992 Free PMC article.

5

CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas.

Paz MF, Yaya-Tur R, Rojas-Marcos I, Reynes G, Pollan M, Aguirre-Cruz L, García-Lopez JL, Piquer J, Safont MJ, Balaña C, Sanchez-Cespedes M, García-Villanueva M, Arribas L, Esteller M. Paz MF, et al. Among authors: esteller m. Clin Cancer Res. 2004 Aug 1;10(15):4933-8. doi: 10.1158/1078-0432.CCR-04-0392. Clin Cancer Res. 2004. PMID: 15297393

6

Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.

Ropero S, Setien F, Espada J, Fraga MF, Herranz M, Asp J, Benassi MS, Franchi A, Patiño A, Ward LS, Bovee J, Cigudosa JC, Wim W, Esteller M. Ropero S, et al. Among authors: esteller m. Hum Mol Genet. 2004 Nov 15;13(22):2753-65. doi: 10.1093/hmg/ddh298. Epub 2004 Sep 22. Hum Mol Genet. 2004. PMID: 15385438

7

A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation.

Alvarez S, Diaz-Uriarte R, Osorio A, Barroso A, Melchor L, Paz MF, Honrado E, Rodríguez R, Urioste M, Valle L, Díez O, Cigudosa JC, Dopazo J, Esteller M, Benitez J. Alvarez S, et al. Among authors: esteller m. Clin Cancer Res. 2005 Feb 1;11(3):1146-53. Clin Cancer Res. 2005. PMID: 15709182

8

Aberrant DNA methylation as a cancer-inducing mechanism.

Esteller M. Esteller M. Annu Rev Pharmacol Toxicol. 2005;45:629-56. doi: 10.1146/annurev.pharmtox.45.120403.095832. Annu Rev Pharmacol Toxicol. 2005. PMID: 15822191 Review.

9

Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.

Agrelo R, Setien F, Espada J, Artiga MJ, Rodriguez M, Pérez-Rosado A, Sanchez-Aguilera A, Fraga MF, Piris MA, Esteller M. Agrelo R, et al. Among authors: esteller m. J Clin Oncol. 2005 Jun 10;23(17):3940-7. doi: 10.1200/JCO.2005.11.650. Epub 2005 May 2. J Clin Oncol. 2005. PMID: 15867203

10

The epigenetic breakdown of cancer cells: from DNA methylation to histone modifications.

Ballestar E, Esteller M. Ballestar E, et al. Among authors: esteller m. Prog Mol Subcell Biol. 2005;38:169-81. doi: 10.1007/3-540-27310-7_7. Prog Mol Subcell Biol. 2005. PMID: 15881895 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

754 results

Search Page